Consistent with our data, Yang et al. found that GIGYF2 acts as a tumor suppressor to negatively regulate AKT/Bax/Caspase-3 signaling, and thus control cell death/survival in glioma cells (Yang et al. 2021). This evidence concerns the gene BAX and central nervous system cancer.